17 alpha-hydroxylase deficiency other diagnostic studies: Difference between revisions
No edit summary |
|||
| Line 11: | Line 11: | ||
:*[[Hyperplasia]] | :*[[Hyperplasia]] | ||
:*Poorly defined | :*Poorly defined zone borders | ||
:*Intermingling of the [[chromaffin]] and cortical cells | :*Intermingling of the [[chromaffin]] and cortical cells | ||
| Line 17: | Line 17: | ||
* Amniotic fluid 11-deoxycortisol and oligonucleotide hybridization of deoxyribonucleic acid (DNA) obtained from chorionic villus biopsies. | * Amniotic fluid 11-deoxycortisol and oligonucleotide hybridization of deoxyribonucleic acid (DNA) obtained from chorionic villus biopsies. | ||
* DNA analysis<ref> Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency. Wikipedia (2016. https://en.wikipedia.org/wiki/Congenital_adrenal_hyperplasia_due_to_17_alpha-hydroxylase_deficiency Accessed on February 4, 2016</ref> | * DNA analysis<ref> Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency. Wikipedia (2016. https://en.wikipedia.org/wiki/Congenital_adrenal_hyperplasia_due_to_17_alpha-hydroxylase_deficiency Accessed on February 4, 2016</ref> | ||
== References == | == References == | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 20:15, 7 February 2016
|
Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
17 alpha-hydroxylase deficiency other diagnostic studies On the Web |
|
American Roentgen Ray Society Images of 17 alpha-hydroxylase deficiency other diagnostic studies |
|
FDA on 17 alpha-hydroxylase deficiency other diagnostic studies |
|
CDC on 17 alpha-hydroxylase deficiency other diagnostic studies |
|
17 alpha-hydroxylase deficiency other diagnostic studies in the news |
|
Blogs on 17 alpha-hydroxylase deficiency other diagnostic studies |
|
Risk calculators and risk factors for 17 alpha-hydroxylase deficiency other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Immunohistochemical staining of the adrenal gland may be used for the diagnosis of congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency and it demonstrates hyperplasia, poorly defined zonation, and intermingling of the chromaffin and cortical cells.
Other Diagnostic Studies
- Immunohistochemical staining of the adrenal gland may be used in patients with 17 alpha-hydroxylase deficiency and it demonstrates:[1]
- Poorly defined zone borders
- Intermingling of the chromaffin and cortical cells
- Amniotic fluid 11-deoxycortisol and oligonucleotide hybridization of deoxyribonucleic acid (DNA) obtained from chorionic villus biopsies.
- DNA analysis[2]
References
- ↑ https://en.wikipedia.org/wiki/Congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency URL Accessed on 10/15/2015
- ↑ Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency. Wikipedia (2016. https://en.wikipedia.org/wiki/Congenital_adrenal_hyperplasia_due_to_17_alpha-hydroxylase_deficiency Accessed on February 4, 2016